V-0219

CAS No. 878453-71-5

V-0219( —— )

Catalog No. M28512 CAS No. 878453-71-5

V-0219 is a positive allosteric modulator of GLP-1 and can be used in studies about obesity-associated diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 191 In Stock
10MG 327 In Stock
25MG 604 In Stock
50MG 906 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    V-0219
  • Note
    Research use only, not for human use.
  • Brief Description
    V-0219 is a positive allosteric modulator of GLP-1 and can be used in studies about obesity-associated diabetes.
  • Description
    V-0219 is a positive allosteric modulator of GLP-1 and can be used in studies about obesity-associated diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    878453-71-5
  • Formula Weight
    410.43
  • Molecular Formula
    C20H25F3N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (243.65 mM)
  • SMILES
    FC(F)(F)C=1C=CC(=CC1)C2=NOC(=N2)CN3CCCC(C3)CN4CCOCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tirzepatide

    Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).

  • Semaglutide Acetate

    Semaglutide Acetate is an agonist of a glucagon-like peptide 1 (GLP-1) receptor and can be used in studies about the treatment of type 2 diabetes.

  • Albiglutide TFA

    Albiglutide TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).